Therefore, this study aims to perform a comprehensive genomic analysis to assess the influence of overexpression of MYO1E in NSCLC and whether there are differences in survival and mortality risk in NSCLC depending on both DNA methylation and RNA expression of MYO1E. The gene discussed is MYO1E; the disease is non-small cell lung carcinoma.